Current COVID-19 safety protocols are currently being followed in all of our facilities

EVO ICL™ – EVOlution in Visual Freedom

EVO ICL™

EVOlution in Visual Freedom

What is EVO ICL lens?

The Implantable Collamer Lens (ICL) for nearsightedness and astigmatism is a refractive lens also known as a phakic IOL. “Phakic” meaning that the natural lens of the eye is in place, and “IOL” meaning intraocular lens, or a lens inside the eye. The EVO ICL is a posterior chamber implant that is introduced through a small incision in the eye and is placed behind the iris (the colored part of the eye), and in front of the natural crystalline lens in order to improve your nearsightedness and astigmatism.

EVO-ICL-Lenses

Come in and talk to Us!

Benefits of EVO ICL

  • Provides clear, sharp vision 1,2
  • 20 to 30 minute procedure
  • Quick recovery time
  • Removable by your doctor
  • Offers UV protection
  • Not visible once in place
  • Can treat nearsightedness with or without astigmatism
  • For patients who may not be candidates for
    LASIK or other vision correction procedures
    due to thin corneas 3,4
  • Does not cause dry eye syndrome 5
  • Excellent vision both day and night 6,7
  • Over 2 million ICLs distributed world-wide
    99.4% of patients surveyed would have the
  • EVO lens procedure again 8

Easy 20-30 Minute Surgical Proceedure

Pre-Op Eye Exam

Eye Drops
Administered

Small Opening

Lens Insertion and
Positioning

Post Op & Check-up

Cost and Financing for EVO ICL

The cost of an EVO ICL procedure can vary depending on your personalized treatment plan. Many EVO ICL patients look forward to spending less in the long run with the EVO ICL compared to the continued costs of contacts and glasses. Ask about financing options and payment plans that may be available for your EVO ICL procedure.

Is EVO ICL Right for Me?

EVO ICL is well-suited for a wide variety of people. Ideal candidates for EVO ICL are aged 21 to 45 with nearsightedness, with or without astigmatism, and have maintained a stable prescription for at least one year. If you are seeking a solution to decrease or eliminate the cost and frustration of traditional contacts or glasses, EVO may be your answer. Contact us to discuss if EVO ICL is right for you.

STAAR EVO

EVO ICL

EVO
EVO ICL lens is an implant that corrects vision without removing any corneal tissue.

LASIK

LASIK

LASIK is a two-step laser vision correction surgery where a flap is made on the surface of the eye called the cornea, and the underlying layers are reshaped with an excimer laser to correct vision.

PRK

PKR

PRK is a laser vision procedure similar to LASIK but no corneal flap is created. The top layer of the cornea called the epithelium is removed, and the underlying tissue is reshaped to correct vision.

Important Safety Information
The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses. To determine if you are an appropriate candidate for EVO Visian ICL surgery, you should have a complete eye examination and talk with your eye care professional about potential benefits, risks, complications, and recovery time. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if 1) your eye shape is not appropriate; 2) you do not meet the minimum endothelial cell density for your age; 3) you have moderate to severe glaucoma; 4) your vision is not stable; or 5) you are pregnant or nursing.
For additional important safety information, please visit EVOICL.com

[1] Sanders D, Vukich J. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006

[2] Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009

[3] Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481

[4] Gimbel H, et al. Management of myopic astigmatism with phakic intraocular lens implantation. Journal of Cataract & Refractive Surgery, Volume 28, Issue 5, 883 – 886.

[5] Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.

[6]  Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.

[7]  Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.

[8] Packer M. The Implantable Collamer Lens with a central port: review of the literature.  Clinical Ophthalmology  2018: 12: 2427–2438